An Interventional Multidisciplinary Approach to Individualize Blood Pressure Treatment

Not Applicable

Active, not recruiting

• Conditions: Uncontrolled Hypertension

• Registration Number: NCT03209154
• Lead Sponsor: Oslo University Hospital

Brief Summary

The aim of the study is to investigate and explore the most important aspects of drug-adherence in the treatment of hypertension in order to improve treatment and blood pressure control, implying that new knowledge will reduce morbidity and mortality.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2017-07-04
• Study First Submitted QC: 2017-07-04
• Study First Posted: 2017-07-06
• Study Start: 2017-11-01
• Primary Completion: 2022-12-31
• Status Verified: 2025-03
• Last Update Submitted: 2025-03-20
• Last Update Posted: 2025-03-25
• Study Completion: 2025-12-31

Recruitment & Eligibility

• Status: ACTIVE_NOT_RECRUITING
• Sex: All
• Target Recruitment: 1000

Inclusion Criteria

• Signed informed consent
• Uncontrolled hypertension
• A stable medication regimen for at least 4 weeks of ≥ 2 antihypertensive agents
• No planned changes in antihypertensive drugs

Exclusion Criteria

• Withdrawal of consent
• 24-h systolic ambulatory blood pressure >/= 170 mmHg
• Patients with inadequate Norwegian language skills
• Positive pregnancy test
• Known alcohol or drug abuse
• estimated glomerular filtration rate <30 mL/min/1.73m2
• Albumin/creatinin ratio >300 mg/mmol
• Any reason why, in the opinion of the investigator, the patient should not participate

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
Blood pressure control	3 months after baseline	Change in systolic daytime ambulatory blood pressure.

Trial Locations

Locations (1)

Oslo University Hospital; 🇳🇴 Oslo, Norway